Shortly after his first opening-round defeat on Court-Philippe Chatrier, Rafael Nadal arrived at the press conference room in a jovial mood. After a career of dominance at Roland Garros, where he has so often been untouchable even against some of the sport's greatest players, he would have been forgiven for feeling a sense of injustice and frustration with a straight-sets defeat in the first round against Alexander Zverev. Instead, he felt progress. "I was not that far," Nadal said. "That's my feeling."
His demeanour further underlined what has been increasingly clear over the past few weeks. If this really is the end and retirement is imminent it will be because his body made the decision, not his mind. It seems clear that the player who turns 38 next week would love to further elongate his career and he is determined to do everything possible to try.
A month ago, Nadal returned to competition in Barcelona and Madrid still unsure about whether he would even make it to Roland Garros. He had good reason to doubt. After the countless physical issues he has endured, from hip surgery to complications and many unrelated injuries, his ambitions were low. He simply wanted to be sure his body could physically withstand the load of competing at the highest level across the best of five sets.
هذه القصة مأخوذة من طبعة May 29, 2024 من The Guardian.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة May 29, 2024 من The Guardian.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Dewsbury-Hall delivers as Gent hit by goal rush
With every result, Enzo Maresca is making Chelsea believe again.
'My home record is bloody good so it's hard to match that'
Chris Woakes is ready for the challenge of leading England's Test attack in Pakistan and justifying Brendon McCullum's faith in his ability overseas
Brewer to reduce emissions by making beer using heat pump
An independent brewery in West Sussex is poised to become the first in Britain to make its beer using an ultra-high-temperature heat pump in place of an oil boiler.
Carmakers complain of pressure to hit EV targets despite record sales in September
UK electric car sales hit a record high in September, even as bosses from major carmakers told the chancellor, Rachel Reeves, that government targets were putting too much pressure on the industry.
Bank of England monitoring crisis in the Middle East 'extremely closely'
The Bank of England is monitoring the Middle East crisis amid fears that a worsening conflict between Iran and Israel will make it impossible to stabilise oil prices and leave the global economy vulnerable to a 1970s-style energy shock.
'Speak the truth' Russia's opposition is rocked by claims over attack on Navalny ally
When Leonid Volkov, a longtime associate of the late Russian opposition leader Alexei Navalny, was brutally attacked with a hammer outside his home in Lithuania in March, it initially seemed yet another case of the Kremlin hunting down its enemies abroad.
Deaths from Hurricane Helene pass 200 a week after storm
A week after Hurricane Helene made landfall in the US, search-and-rescue teams are continuing to search for missing people in parts of the south-east that were devastated by the storm.
Book claims Trump axed hardline migrant policy after Melania intervened
Melania Trump describes in her new memoir how she made her husband, then president Donald Trump, drop a signature hardline immigration policy under which migrant children were separated from their parents, stoking domestic and international uproar.
Centrepoint says councils illegally turn away homeless young people
Hundreds of homeless young people, including dozens who are pregnant or have children, are being illegally turned away by councils when they ask for help.
White women eligible to donate stem cells on NHS for first time
Millions of women are now eligible to donate stem cells on the NHS for the first time amid rising demand for life-saving transplants and a drive to reduce reliance on expensive imports.
